Skip to main

A monochrome reading of the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500 indexed against the literature.

CONTACT

Write to the archive.

Questions about our GLOW peptide research coverage, citation corrections, or editorial inquiries.

Editorial Contact

Glow Medicinal archives editorial summaries of the peer-reviewed research on the GLOW peptide blend — GHK-Cu, BPC-157, and TB-500. No clinic, vendor, or pharmacy stands behind it, so we cannot answer questions about personal health, dosing recommendations, or peptide sourcing.

For citation corrections: if you have identified an error — a wrong PMID, a misquoted finding, a broken DOI — please reach out. We take citation accuracy seriously and will correct errors promptly.

For editorial inquiries: questions about our coverage, scope, or methodology are welcome.

What we cannot help with: sourcing questions, vendor recommendations, personal health questions, prescription inquiries, clinical consultations, or protocol advice. This site is an archive of published science.

A Note on Our Scope

The GLOW peptide blend literature is constituent-level: GHK-Cu, BPC-157, and TB-500 have each been studied independently, but no controlled trial has examined the three in combination [23]. If you have found a published controlled trial we have not covered, we want to know. Correct, complete, and cited: that is the standard we hold ourselves to.